26.18
Tectonic Therapeutic Inc stock is traded at $26.18, with a volume of 258.81K.
It is up +3.09% in the last 24 hours and up +17.82% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$25.39
Open:
$25.4
24h Volume:
258.81K
Relative Volume:
1.23
Market Cap:
$489.88M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+11.36%
1M Performance:
+17.82%
6M Performance:
-11.37%
1Y Performance:
+52.21%
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TECX
Tectonic Therapeutic Inc
|
26.18 | 462.38M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-21-25 | Initiated | Truist | Buy |
Jun-11-25 | Resumed | Raymond James | Outperform |
Apr-21-25 | Initiated | Mizuho | Outperform |
Nov-20-24 | Initiated | Raymond James | Outperform |
Aug-22-24 | Initiated | Wells Fargo | Overweight |
Jun-26-24 | Initiated | Piper Sandler | Overweight |
Jun-24-24 | Initiated | TD Cowen | Buy |
Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-15-21 | Initiated | BTIG Research | Buy |
May-27-21 | Initiated | Needham | Buy |
Mar-09-21 | Initiated | Barclays | Overweight |
Mar-02-21 | Initiated | Stifel | Hold |
Nov-11-20 | Initiated | Berenberg | Buy |
Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
Jun-27-19 | Initiated | Mizuho | Buy |
Apr-05-19 | Initiated | Janney | Buy |
Oct-10-18 | Initiated | Guggenheim | Buy |
Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
Sep-17-18 | Initiated | H.C. Wainwright | Buy |
Jul-16-18 | Initiated | Wedbush | Outperform |
Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Institutional scanner results for Tectonic Therapeutic Inc.July 2025 Highlights & Real-Time Market Sentiment Alerts - Newser
Using Python tools to backtest Tectonic Therapeutic Inc. strategies2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
Analyzing Tectonic Therapeutic Inc. with multi timeframe chartsQuarterly Trade Summary & Growth Focused Entry Point Reports - Newser
Tectonic Therapeutic Inc. stock retracement – recovery analysisPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Relative strength of Tectonic Therapeutic Inc. in sector analysisJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - Newser
Using flow based indicators on Tectonic Therapeutic Inc.2025 Price Action Summary & Long-Term Growth Plans - Newser
Quantitative breakdown of Tectonic Therapeutic Inc. recent moveTrade Risk Report & Reliable Entry Point Alerts - Newser
Combining price and volume data for Tectonic Therapeutic Inc.July 2025 Trends & Fast Gaining Stock Strategy Reports - Newser
How Tectonic Therapeutic Inc. stock performs during market volatilityJuly 2025 Pullbacks & Long-Term Growth Plans - Newser
Tectonic Therapeutic Inc.’s volatility index tracking explainedWeekly Profit Summary & Verified Entry Point Signals - Newser
Using data models to predict Tectonic Therapeutic Inc. stock movementIPO Watch & Weekly Watchlist for Hot Stocks - Newser
Real time breakdown of Tectonic Therapeutic Inc. stock performanceQuarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser
Combining machine learning predictions for Tectonic Therapeutic Inc.Market Activity Recap & Daily Volume Surge Signals - Newser
How to escape a deep drawdown in Tectonic Therapeutic Inc.Market Risk Analysis & Weekly High Potential Stock Alerts - Newser
Risk adjusted return profile for Tectonic Therapeutic Inc. analyzed2025 Trading Recap & Growth Oriented Trade Recommendations - Newser
What makes Tectonic Therapeutic Inc. stock price move sharplyJuly 2025 Decliners & Weekly Breakout Stock Alerts - thegnnews.com
Published on: 2025-08-17 05:45:57 - Newser
Regression analysis insights on Tectonic Therapeutic Inc. performanceTrade Risk Assessment & Fast Moving Stock Trade Plans - Newser
What high frequency data says about Tectonic Therapeutic Inc.July 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Is Tectonic Therapeutic Inc. stock reversal real or fakeWeekly Trade Review & Capital Efficiency Focused Strategies - Newser
Will Tectonic Therapeutic Inc. outperform the marketJuly 2025 Pullbacks & Reliable Breakout Forecasts - Newser
Is Tectonic Therapeutic Inc. affected by consumer sentimentJuly 2025 Opening Moves & Growth Focused Investment Plans - thegnnews.com
How moving averages guide Tectonic Therapeutic Inc. tradingEarnings Miss & Community Driven Trade Alerts - Newser
What analysts say about Tectonic Therapeutic Inc. stock outlookEarnings Risk Report & Community Verified Trade Alerts - Newser
Tectonic Therapeutic Inc. stock chart pattern explainedInsider Buying & Verified Entry Point Detection - Newser
Should I hold or sell Tectonic Therapeutic Inc. nowDollar Strength & Weekly High Return Opportunities - sundaytimes.kr
What does recent volatility data suggest for Tectonic Therapeutic Inc.Buy Signal & Weekly Breakout Watchlists - Newser
Published on: 2025-08-15 16:58:27 - Newser
What institutions are buying Tectonic Therapeutic Inc. stock now2025 Price Momentum & AI Based Trade Execution Alerts - Newser
Institutional Tools Highlight Unusual Flow in Tectonic Therapeutic Inc.Analyst Downgrade & Weekly Watchlist of Top Performers - beatles.ru
Published on: 2025-08-14 05:03:55 - Newser
Published on: 2025-08-13 09:01:10 - Newser
Tectonic Therapeutic’s Strategic Expansion and Financial Stability Justify Buy Rating - TipRanks
Sectors Driving Future Growth for Tectonic Therapeutic Inc. StockAI Triggered Buy Zone Forecast System - Newser
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Tectonic Therapeutic Inc Stock (TECX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
45,858 |
767,204 |
1,449,652 |
SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
21,071 |
311,020 |
1,403,794 |
SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
16.31 |
9,478 |
154,586 |
4,334,846 |
SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
8,092 |
135,379 |
4,325,368 |
SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
3,718 |
54,880 |
4,317,276 |
SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
412,500 |
7,053,750 |
1,382,723 |
SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
87,500 |
1,496,250 |
4,313,558 |
MCGUIRE TERRANCE | Director |
Apr 07 '25 |
Sale |
17.10 |
500,000 |
8,550,000 |
573,062 |
SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
50.00 |
660,000 |
33,000,000 |
970,223 |
SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
54.14 |
129,294 |
6,999,977 |
4,226,058 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):